Zealand Pharma A/S
OTC:ZLDPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zealand Pharma A/S
OTC:ZLDPF
|
DK |
|
G-Tec Jainx Education Ltd
NSE:GTECJAINX
|
IN |
|
Excelerate Energy Inc
NYSE:EE
|
US |
|
Batisoke Soke Cimento Sanayii TAS
IST:BSOKE.E
|
TR |
|
Shanta Gold Ltd
LSE:SHG
|
GG |
|
J
|
JMT Co Ltd
KOSDAQ:094970
|
KR |
|
Vmoto Ltd
ASX:VMT
|
AU |
|
Manchester United PLC
NYSE:MANU
|
UK |
|
Television Broadcasts Ltd
HKEX:511
|
HK |
|
WSP Global Inc
TSX:WSP
|
CA |
|
A
|
Astra Graphia Tbk PT
IDX:ASGR
|
ID |
|
T
|
Titijaya Land Bhd
KLSE:TITIJYA
|
MY |
|
Groupe Pizzorno Environnement SA
PAR:GPE
|
FR |
|
H
|
Hota Industrial Mfg. Co Ltd
TWSE:1536
|
TW |
|
F
|
Favelle Favco Bhd
KLSE:FFB
|
MY |
Bankruptcy Probability
Zealand Pharma A/S's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Zealand Pharma A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
Zealand Pharma A/S
CSE:ZEAL
|
20.3B DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
373.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
69.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Zealand Pharma A/S's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Zealand Pharma A/S has total debt of 383.1m DKK. This includes both short-term (0 DKK) and long-term (383.1m DKK) debt.
You can find a full breakdown on its Balance Sheet.
